Insider buying
~$250K6,033 sh @ $41.42
Traded Dec 11, 2024 · filed 2 days later
The CEO of QuidelOrtho paid $250K out of pocket for QuidelOrtho shares. It was the first purchase in over a year.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
6 tracked managers disclosed the same change for Q3 2024. From a 13F filed Nov 14, 2024 covering holdings at Sep 30, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Increased
Compared with the manager's Q2 2024 13F
593,157
890,936
+50.2%
Share count drives classification; reported value also moves with price
0.41%
Within the filing's reported positions, not the manager's total assets
6
For Q3 2024
Insider buying
Traded Dec 11, 2024 · filed 2 days later
The CEO of QuidelOrtho paid $250K out of pocket for QuidelOrtho shares. It was the first purchase in over a year.
Insider selling
Traded Nov 21, 2024 · filed the same dayNot reported under a pre-arranged trading plan
A major shareholder of QuidelOrtho sold $292M of QuidelOrtho shares. The filing does not indicate a pre-arranged trading plan.
Fund moves
6 tracked managers disclosed the same change for Q3 2024. From a 13F filed Nov 14, 2024 covering holdings at Sep 30, 2024 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.